Evidence map›Paper›PMID 42909403›Full record

ArticleFrontiers in pharmacology2026

Barrier model selection alters apparent diclofenac permeation parameters: a controlled

Filip Dugonik, Urška Jeršič, Lejla Kač, Lidija Gradišnik, Tanja Zidarič, Uroš Maver, Tina Maver

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Filip Dugonik *Institute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Urška Jeršič *Institute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Lejla Kač *Institute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Lidija GradišnikInstitute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Tanja ZidaričInstitute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Uroš MaverInstitute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Tina MaverInstitute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Maribor, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Synthetic membranes and keratinocyte-based constructs are both used as accessible alternatives to Methods: Permeation studies were performed using Franz diffusion cells in an internally controlled experimental design. Both formulations were tested in triplicate under identical conditions, including receptor medium, temperature, sampling protocol, and analytical method. Steady-state flux (Jss), permeability coefficient (Kp), lag time ( Results: Barrier model selection affected the apparent permeation behavior of diclofenac. Strat-M® detected a statistically significant difference in steady-state flux between Voltaren® and Olfen®, whereas no statistically significant between-formulation difference was detected with the HaCaT construct under the same experimental conditions. Lag time was the parameter most strongly influenced by barrier selection and was consistently shorter with the HaCaT construct than with Strat-M®. Discussion: Under identical IVPT conditions, Strat-M® and the HaCaT-based epidermal construct generated different apparent permeation profiles and yielded different comparative assessments of Voltaren® and Olfen®. This model-dependent divergence underscores the need to justify barrier selection explicitly and to consider its limitations when interpreting comparative IVPT data.

Indexed as

barrier modeldiclofenacFranz diffusion cellHaCaTIn vitro permeation testingpermeation profileStrat-M®topical gel

Identifiers

PMID42909403
PMCPMC13684325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.